ONKI3 | Medical Subject Headings

The ONKI is provided as a part of the ONKI Living Lab - an open lab for testing the latest semantic web technologies in practice, with real users like you. Currently, over 10 000 people are using ONKI each month.

We hope you like the ONKI service and enjoy using it for your purposes!

If you encounter any problems or have improvement ideas, please contact the ONKI team. We are also very much interested in your success stories in using ONKI - please share your experiences!

The ONKI Team

Jouni Tuominen, Living Lab contact person, APIs, widgets, publishing of ontologies, etc.
Eero Hyvönen, professor, head of research group

Former members: Kim Viljanen, Rami Alatalo.

Building the future of the Semantic Web and beyond.

SeCo's homepage
For the latest semantic news, follow us on Twitter and fan us on Facebook!

How can we help you?

Live presentations about ONKI: what it is? how to use it?
Support for creating and publishing ontologies.
Online technical support for using ONKI.
Co-operation in projects.
And more, please ask.

suomeksi på svenska in English

The way property values are displayed: value/row values side by side

The way concept relations are shown: separately in hierarchy

Hypersensitivity

Loading results...


Hierarchy:	Medical Subject Headings (MeSH) ∟ Immune System Diseases ∟ Hypersensitivity 7 coordinate concepts 8 subordinate concepts ∟ D006967Q000139* \| ∟ Drug Hypersensitivity \| ∟ Environmental Illness \| ∟ Hypersensitivity, Delayed \| ∟ Hypersensitivity, Immediate \| ∟ Immune Complex Diseases \| ∟ Latex Hypersensitivity \| ∟ Wissler's Syndrome ∟ Autoimmune Diseases \| ∟ Blood Group Incompatibility \| ∟ Glomerulonephritis, Membranoproliferative \| ∟ Graft vs Host Disease \| ∟ Immunologic Deficiency Syndromes \| ∟ Immunoproliferative Disorders \| ∟ Purpura, Thrombocytopenic X
Broader terms:	Medical Subject Headings (MeSH) ∟ Immune System Diseases ∟ Hypersensitivity Immune System Diseases > Medical Subject Headings (MeSH) X
Narrower terms:	D006967Q000139* \| Drug Hypersensitivity \| Environmental Illness \| Hypersensitivity, Delayed \| Hypersensitivity, Immediate \| Immune Complex Diseases \| Latex Hypersensitivity \| Wissler's Syndrome X
Annotation:	IM; use qualif with caution; /drug ther: consider also ANTI-ALLERGIC AGENTS; atopic = HYPERSENSITIVITY, IMMEDIATE; to food = FOOD HYPERSENSITIVITY; to light = PHOTOSENSITIVITY DISORDERS; RESPIRATORY HYPERSENSITIVITY is also available; in occup or environ exposure MULTIPLE CHEMICAL SENSITIVITY is also available X
historyNote*:	66; was ALLERGY 1963-65 X
publicMeSHNote*:	66; was ALLERGY 1963-65 X
Scope note:	Altered reactivity to an antigen, which can result in pathologic reactions upon subsequent exposure to that particular antigen. X
activeMeSHYear*:	2000 \| 2001 \| 2002 \| 2003 \| 2004 \| 2005 \| 2006 \| 2007X
dateCreated*:	1999-01-01X
dateEstablished*:	1966-01-01X
dateRevised*:	1999-11-03X
recordAuthorizer*:	sjnX
recordMaintainer*:	kleX
recordOriginator*:	NLMX
Related term:	Anti-Allergic Agents \| Desensitization, Immunologic \| Multiple Chemical Sensitivity X
Type:	Concept X
Coordinate terms:	Autoimmune Diseases \| Blood Group Incompatibility \| Glomerulonephritis, Membranoproliferative \| Graft vs Host Disease \| Immunologic Deficiency Syndromes \| Immunoproliferative Disorders \| Purpura, Thrombocytopenic X
URI:	X
Labels and equivalent concepts:	Yliherkkyys (fi) Yliherkkyydet (fi, replaced) Liikaherkkyys (fi, replaced) Idiosynkrasia (fi, replaced) Hypersensitiviteetti (fi, replaced) Yliherkkyysreaktio (fi, replaced) Yliherkkyysreaktiot (fi, replaced) Hypersensitiviteetit (fi, replaced) Hypersensitiivisyys (fi, replaced) Allergiat (fi, replaced) Allergia / allerginen reaktio, määrittämätön (fi, replaced) Allergia (fi, replaced) Allerginen reaktio (fi, replaced) Allerginen sairaus (fi, replaced) Allergisuus (fi, replaced) Allergiset sairaudet (fi, replaced) Allergiset reaktiot (fi, replaced) Överkänslighet (sv) Allergi (sv, replaced) Allergy (en, replaced) Reactio allergica (la-FI, replaced) Idiosyncrasia (la-FI, replaced) X
Share:	X